DeborahJaneWexlerMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Clinical director, MGH Diabetes Center Associate Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Wexler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wexler's full profile

Already have an account?

Office
50 Staniford St
Diabetes Center
Boston, MA 02114
Phone+1 617-726-8722

Fax+1 617-724-8534

Education & Training

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2007
Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
Yale School of MedicineClass of 2000

Certifications & Licensure

MA State Medical License 2002 - 2027
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Top Doctor Castle Connolly, 2018-2022

Clinical Trials

Effect of Inpatient Diabetes Management on Outpatient Glycemic Control Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control Start of enrollment: 2011 Dec 01
Completed
Not Applicable
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Understanding and Optimizing Care for Young Adults With Type 1 and Type 2 Diabetes Mellitus Transitioning to Adult Care Start of enrollment: 2021 Oct 01
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies.
Alexander J Blood, Lee-Shing Chang, Caitlin Colling, Gretchen Stern, Daniel Gabovitch
American Heart Journal. 2025-04-01
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors.
HoJin Shin, Julie M Paik, Brendan M Everett, Elyse DiCesare, Caroline Alix
JAMA Internal Medicine. 2025-03-01
Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study.
Helen Tesfaye, Julie M Paik, Heidi Zakoul, Niklas Schmedt, Deborah J Wexler
Diabetes, Obesity & Metabolism. 2025-02-28

Journal Articles

Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: A Randomized Cross-over Trial
Deborah J Wexler, Seth A Berkowitz, Linda M Delahanty, Journal of General Internal Medicine

Lectures

Does the Effect of Lifestyle Intervention for Individuals with Diabetes Vary by Food Insecurity Status? A Preplanned Subgroup Analysis of the REAL HEALTH Randomized Cl...
Boston, MA - 6/15/2014

Press Mentions

Diabetes Day Spotlights Achievements, Current InvestigationsJune 6th, 2024
Out of ControlAugust 12th, 2021
GRADE: GLP-1 Agonists, Insulin More Effective Than Other Diabetes DrugsJune 29th, 2021
Join now to see all

Grant Support

Identifying Effective Treatment Strategies For Older Adults With DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
Effective Inpatient Diabetes Management And The Transition To Outpatient CareNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011

Committees

member, Standards of Medical Care in Diabetes - 2015
member, Standards of Medical Care in Diabetes - 2016